An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Condition: Gaucher Disease, Type 3 Interventions: Drug: Gene therapy; Drug: Enzyme Replacement Agent Sponsor: AVROBIO Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials